1-8 of 8
Edith A Nutescu, PharmD, MS
Close
Sort by
Journal Articles

Correction of Point-of-Care International Normalized Ratio (INR) Values in Patients with Sickle Cell Disease

Syeda Rahman, Andrew Srisuwananukorn, MD, Robert E. Molokie, MD, Michel Gowhari, DO, Franklin Njoku, MD, Faiz Ahmed Hussain, MD, Edith A. Nutescu, PharmD., MS, FCCP, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Jin Han
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-137166
Published: 2020
Journal Articles

A Risk Assessment Model for the Identification of Sickle Cell Disease Patients at Risk for Venous Thromboembolism

Jifang Zhou, MD, Gregory Sampang Calip, PharmD, MPH, PhD, Edith A. Nutescu, PharmD., MS, FCCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 3568.
https://doi.org/10.1182/blood-2018-99-119286
Published: 2018
Journal Articles

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Jifang Zhou, MD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP, William Galanter, MD PhD MS, Surrey M. Walton, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Andrew Srisuwananukorn, MD, Gregory Sampang Calip, PharmD, MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4817.
https://doi.org/10.1182/blood-2018-99-119039
Published: 2018
Journal Articles

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Gregory Sampang Calip, PharmD, MPH, PhD, Jifang Zhou, MD, Karen Sweiss, PharmD, Pritesh Patel, MD, Alemseged Ayele Asfaw, MSc, B Pharm, Todd Lee, PharmD, PhD, Brian C.-H. Chiu, PhD, Edith A. Nutescu, PharmD., MS, FCCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 4693.
https://doi.org/10.1182/blood-2018-99-116867
Published: 2018
Journal Articles

Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas

Inyoung Lee, MS, BPharm, Sruthi Adimadhyam, BPharm, MS, Edith A. Nutescu, PharmD., MS, FCCP, Karen Sweiss, PharmD, Pritesh Patel, MD, Gregory Sampang Calip, PharmD, MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2280.
https://doi.org/10.1182/blood-2018-99-116938
Published: 2018
Journal Articles

Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study

Jifang Zhou, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 2139.
https://doi.org/10.1182/blood.V130.Suppl_1.2139.2139
Published: 2017
Journal Articles

Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery

Steven Deitelzweig, MD, Edith A Nutescu, PharmD, MS, James Meyer, PharmD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Alpesh N Amin, MDMBA
Journal: Blood
Blood (2014) 124 (21): 4852.
https://doi.org/10.1182/blood.V124.21.4852.4852
Published: 2014
Journal Articles

Post Hoc Analysis of Desirudin Versus Enoxaparin for Thromboprophylaxis in High-Risk Patients Undergoing Elective Hip Replacement Surgery

Jerrold Levy, MD, Edith A Nutescu, PharmD, MS, James Meyer, PharmD
Journal: Blood
Blood (2014) 124 (21): 5086.
https://doi.org/10.1182/blood.V124.21.5086.5086
Published: 2014